外泌体lncRNA-HULC通过SDF-1/CXCR4轴促进结肠癌干细胞侵袭转移的功能与机制研究

批准号:
81772627
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
曾珊
依托单位:
学科分类:
H1810.肿瘤干细胞
结题年份:
2021
批准年份:
2017
项目状态:
已结题
项目参与者:
申竑、杨浩、袁伟杰、彭芳、马俊丽、邓甘露、尹玲、韩莹、蔡长景
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
结肠癌干细胞(CCSCs)是导致肿瘤转移的“元凶”,但需要SDF-1/CXCR4轴传导的参与。而上皮-间质转化(EMT)是CCSCs形成与转移的分子基础,长链非编码RNA(lncRNA)是重要的EMT调控因子。我们前期发现CXCR4+的CCSCs外泌体lncRNA-HULC表达显著升高,而HULC可诱导CCSCs的EMT。但CCSCs外泌体HULC是否与如何参与结肠癌的器官靶向性转移尚待阐明。本项目拟运用流式细胞术、低密度基因芯片、蛋白悬液芯片、小动物活体成像等技术,在细胞学、小鼠模型、临床样本三个层次,逐步验证CCSCs外泌体HULC通过调控miR-9,进而增强SDF-1/CXCR4轴传导,促进CCSCs的EMT和侵袭转移,导致结肠癌预后不良,及其细胞信号传导和下游调控靶基因相互作用的分子机理。为利用外泌体做为新型治疗载体,阻断结肠癌的复发转移,改善患者预后提供理论基础和科学证据。
英文摘要
Colon cancer stem cells (CCSCs) are the key causes being responsible for the invasion and metastasis of colon cancer, with the conduction of stromal-derived factor-1 (SDF-1) / CXC chemokine receptor (CXCR) axis. Epithelial mesenchymal transition (EMT) plays as the molecular basis of the formation and metastasis of CCSCs. Exosomes-derived long chain non-coding RNA (lncRNA) is a critical regulator of CCSCs EMT. We previously found that lncRNA-HULC (highly up-regulated in liver cancer) expression increased significantly in the exosomes of CCSCs with CXCR4+ phenotype. Exosomes-derived HULC could induce the EMT of CCSCs and was closely related to the metastasis of colon cancer. However, the regulation and the molecular mechanisms of exosomes-derived HULC in the organ targeting metastasis of CCSCs and the patients’ prognosis remain to be elucidated. Applying multi-techniques including flow cytometry, TaqMan Low Density Arrays, Bio-Plex Protein Suspension Array, and in vivo imaging in small animal, the present study aims to prove our scientific hypothesis in independent experiments on CCSCs, mice model and clinical colon cancer specimens, that HULC in CCSCs-derived exosomes induces EMT via miR-9 regulation and SDF-1/CXCR axial transduction, so as to promote the invasion and metastasis of CCSCs, and results in a poor prognosis of colon cancer patients. Meanwhile, the interacted cellular signaling pathways and the targeting downstream genes regulated by HULC in CCSCs will also be explored. The findings achieved from the present project are supposed to provide us with more theoretical basis and experimental evidences to improve the patients’ prognosis through a block of the invasion and metastasis of colon cancer, as we use the exosomes as a novel therapeutic vector.
结肠癌干细胞(CCSCs)是导致肿瘤转移的“元凶”,但需要SDF-1/CXCR4轴传导的参与。而上皮-间质转化(EMT)是CCSCs形成与转移的分子基础,长链非编码RNA(lncRNA)是重要的EMT调控因子。我们前期发现CXCR4+的CCSCs外泌体lncRNA-HULC表达显著升高,而HULC可诱导CCSCs的EMT。但CCSCs外泌体HULC是否与如何参与结肠癌的器官靶向性转移尚待阐明。. 该项目除应用常规医学实验技术,还综合灵活运用定量RT-PCR、 Western 杂交、免疫荧光、流式细胞术、激光共聚焦显微镜、PCR Array、小动物活体成像等多项先进科研手段,从CCSCs细胞、NOD/SCID小鼠活体模型和回顾性/前瞻性临床样本三个研究层次,逐步深入,相互验证:CCSCs外泌体HULC通过调控miR-9,及miR-9靶基因KRT80,进而增强SDF-1/CXCR4轴传导,促进CCSCs的EMT和对肝组织的“靶向集聚”,导致结肠癌的肝转移和患者的不良预后。. 本项目研究成果进一步明确了外泌体lncRNA-HULC通过诱导EMT,促进结肠癌侵袭转移,导致患者预后不良的分子机理。为利用外泌体做为新型治疗载体,阻断结肠癌的复发转移,改善患者预后提供了理论基础和科学证据。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.
CLEC10A 是一种预后生物标志物,与肺腺癌的临床病理特征和免疫浸润相关
DOI:10.1111/jcmm.16416
发表时间:2021-04
期刊:Journal of cellular and molecular medicine
影响因子:5.3
作者:He M;Han Y;Cai C;Liu P;Chen Y;Shen H;Xu X;Zeng S
通讯作者:Zeng S
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.
COVID-19疫苗的有效性和安全性的全面分析
DOI:10.1016/j.ymthe.2021.08.001
发表时间:2021-09-01
期刊:Molecular therapy : the journal of the American Society of Gene Therapy
影响因子:--
作者:Cai C;Peng Y;Shen E;Huang Q;Chen Y;Liu P;Guo C;Feng Z;Gao L;Zhang X;Gao Y;Liu Y;Han Y;Zeng S;Shen H
通讯作者:Shen H
Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma
对星形胶质细胞介导的胶质母细胞瘤增殖、侵袭和肿瘤免疫微环境信号的新见解
DOI:10.1016/j.biopha.2020.110086
发表时间:2020
期刊:Biomedicine & Pharmacotherapy
影响因子:7.5
作者:Hao Zhang;Yulai Zhou;Biqi Cui;Zhixiong Liu;Hong Shen
通讯作者:Hong Shen
DOI:10.1186/s13046-019-1396-4
发表时间:2019
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:--
作者:Fu Yaojie;Liu Shanshan;Zeng Shan;Shen Hong
通讯作者:Shen Hong
Cyclin E: a potential treatment target to reverse cancer chemoresistance by regulating the cell cycle
Cyclin E:通过调节细胞周期逆转癌症化疗耐药的潜在治疗靶点
DOI:--
发表时间:2020
期刊:American Journal of Translational Research
影响因子:2.2
作者:Yashan Li;Wei Pang;Weihua Guo;Hong Shen
通讯作者:Hong Shen
PRMT5通过USP7依赖性IFNAR1降解抑制I型干扰素反应及DC1s激活促进MSS型结肠癌免疫逃逸的研究
- 批准号:82373275
- 项目类别:面上项目
- 资助金额:49万元
- 批准年份:2023
- 负责人:曾珊
- 依托单位:
去m6A修饰介导tRNAVal剪切产生tRF-RNA3008A结合Ago2蛋白抑制结肠癌增殖和侵袭转移的分子机制研究
- 批准号:81974384
- 项目类别:面上项目
- 资助金额:55.0万元
- 批准年份:2019
- 负责人:曾珊
- 依托单位:
肿瘤靶向性E1A超顺磁纳米载体对宫颈癌的放疗增敏作用及其分子机制的实验研究
- 批准号:81172470
- 项目类别:面上项目
- 资助金额:58.0万元
- 批准年份:2011
- 负责人:曾珊
- 依托单位:
血小板活化因子引起血小板α-颗粒释放的机制探讨
- 批准号:39570816
- 项目类别:面上项目
- 资助金额:8.5万元
- 批准年份:1995
- 负责人:曾珊
- 依托单位:
国内基金
海外基金
